Tau Screening Study in Subjects With Early Symptomatic AD
Status:
Completed
Trial end date:
2018-11-15
Target enrollment:
Participant gender:
Summary
This protocol is designed to serve as a pre-screening study for subjects who are potentially
eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for
inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.